mars 7, 2018
Optimizing Efficiency in Intravitreal Injections
Malosa Medical Announces the Release of the Intravitreal Injection Guide
We are proud to announce the release of our Intravitreal Injection Guide (MMSU1577) – designed to facilitate IVT injections while reducing patient discomfort and anxiety.
Designed by UK-based ophthalmologist, Mr. Salman Waqar, MBBS, FRCOphth, the Intravitreal Injection Guide removes the need for both the drape and speculum as well as standardising the procedure. In effect, the device allows a higher throughput of procedures by eliminating the time-consuming elements of the manual technique.
The guide consists of a curved, triangular base plate which follows the natural contour of the eye and three studs at each corner which ensure stabilization. The cylindrical chamber adjacent to the lash guard allows the injection to be delivered at the precise location and depth of the eye, avoiding the risk of retinal damage.
Intravitreal injections are used to administer therapeutic agents into the vitreous space of wet age-related macular degeneration, retinal vein occlusion and diabetic macular oedema patients. However, many patients feel apprehensive about the procedure, particularly due to the surgical drape, which can cause feelings of claustrophobia, while the use of an eyelid speculum can be uncomfortable. From a surgeon’s perspective, the injection requires careful administration and necessitates the individual to accurately measure the point of inoculation as well as the entry depth and angle of the needle manually.
Mr Waqar designed the device in collaboration with the Torbay and South Devon NHS Foundation and Plymouth Hospitals NHS Trusts under the South West Peninsula NHS Innovation Pathway. The pathway is intended to support staff to develop their ideas.
Dr Phil Hughes, Medical Director of Plymouth Hospitals said: “The Trust was delighted to be involved in such an innovative project which will result in great benefit of thousands of patients.”
Director of Strategy and Innovation at Torbay and South Devon NHS Foundation trust, Ann Wagner, said “We are delighted to have been involved with the development of this device. This project is a perfect example of how we are working in partnership across Devon to make a real difference for our patients and service users.”
Addressing the significance of this development, Mr Waqar said: “This innovation will be very well received, particularly as it is a new and unique design for delivering comfortable, safe and efficient eye injections.”
For further information and media enquiries, please contact: firstname.lastname@example.org
About Malosa Medical™
Malosa Medical™ is a leading manufacturer and supplier of high quality single-use micro-surgical instruments. Established in 2003, Malosa now employs a team of over 250 people committed to producing and developing the very best single-use instruments. With a range of more than 300 instruments and procedure packs, Malosa™ can provide a complete single-use solution for hospitals and clinics. More information about Malosa Medical™ can be found at www.malosa.com.
Malosa Medical™ is part of the Beaver-Visitec International, Inc. ("BVI") group.
About Beaver-Visitec International, Inc.
Headquartered in Waltham, Massachusetts, USA, Beaver-Visitec International develops, manufactures and markets ophthalmic and other specialty microsurgical products. Beaver-Visitec distributes products in over 90 countries worldwide and operates manufacturing facilities in Waltham, MA, USA and Bidford on Avon, U.K. Beaver-Visitec offers products and services for all aspects of Ophthalmic Surgery, including cataract, refractive, oculoplastic, and vitreoretinal sub-specialties as well as other specialty microsurgery procedures. More information about Beaver-Visitec International can be found at www.beaver-visitec.com.